Remove Intellectual Property Remove Licensing Remove Reporting Remove Settlement
article thumbnail

3 Count: Bridgerton Settlement

Plagiarism Today

First off today, Adam Schrader at UPI reports that New York artist Kris Kashtanova has received a copyright registration for a graphic novel entitled Zarya of the Dawn , representing the first known copyright registration granted to a work of AI-generated artwork. The post 3 Count: Bridgerton Settlement appeared first on Plagiarism Today.

article thumbnail

Alvotech and Teva Reach Ustekinumab (STELARA) Settlement with J&J

LexBlog IP

announced that they reached a settlement and license agreement with Johnson & Johnson regarding AVT04, Alvotech’s proposed biosimilar to STELARA (ustekinumab) in the United States. The post Alvotech and Teva Reach Ustekinumab (STELARA) Settlement with J&J appeared first on Big Molecule Watch.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 Count: Notorious Markets 2022

Plagiarism Today

First off today, Chris Cooke at Complete Music Update reports that the United States Trade Representative has released its annual list of “notorious markets” that identifies countries that, according to it, are failing to take adequate action to prevent copyright and other kinds of intellectual property infringement.

Marketing 176
article thumbnail

Formycon/Fresenius Kabi and Samsung Bioepis Settlements with J&J and Janssen Biotech regarding Ustekinumab

LexBlog IP

On August 7, 2023, Formycon AG and Fresenius Kabi announced that they have reached a settlement with Johnson & Johnson (“J&J”) in the United States relating to FYB202, a proposed ustekinumab biosimilar to STELARA®, marketed by J&J. Economic terms of the settlement were not disclosed in the press release.

article thumbnail

Five Men Indicted For Uploading Movies & Then Extorting ‘Pirate’ Downloaders

TorrentFreak

Licensed ‘Copyright Cockroaches’ Early June 2022, news outlets in Taiwan reported that former ultramarathon runner, entrepreneur, political critic, and law graduate Kevin Lin was a suspect in a “copyright cockroach” case. In May 2021, licenses were obtained from Vie Vision Pictures Co.

article thumbnail

Celltrion Stelara (Ustekinumab) Settlement With J&J

LexBlog IP

It has been reported that Celltrion has finalized a settlement with Johnson & Johnson (“J&J”) in the United States relating to CT-P43, Celltrion’s ustekinumab biosimilar to J&J’s STELARA®, which would permit Celltrion to launch the product in the U.S. market on March 7, 2025, if approved by FDA.

article thumbnail

The Corporate Transparency Act (Part 2): Exemptions from the Reporting Requirements

LexBlog IP

The new legislation requires certain entities to report information about their owners, management and the individuals who helped create the entities to the U.S. This edition will provide a more detailed look at the exemptions from reporting requirements under the CTA. b) has an operating presence at a physical office within the U.S.,